Prognostic value of contrast-enhanced MRI in Guillain-Barré syndrome in children

F Althubaiti1, C Guiomard2, F Rivier3

  • 1Département de Neuropédiatrie, CHU de Montpellier, Hôpital Gui de Chauliac, 34295, Montpellier, France; King Abdulaziz University, Department of Pediatrics, 21589, Jeddah, Saudi Arabia.

Insights

Contrast-enhanced MRI aids in diagnosing childhood Guillain-Barré syndrome. However, imaging patterns do not predict short-term or long-term clinical outcomes in pediatric patients.

Area of Science:

  • Pediatric Neurology
  • Neuroradiology
  • Clinical Outcomes Research

Background:

  • Childhood Guillain-Barré syndrome (GBS) is an autoimmune disorder affecting the peripheral nervous system.
  • Contrast enhancement patterns on MRI can indicate nerve root inflammation in pediatric GBS.

Purpose of the Study:

  • To investigate the prognostic value of contrast enhancement patterns in pediatric Guillain-Barré syndrome.
  • To correlate imaging findings with clinical, laboratory, and therapeutic outcomes.

Main Methods:

  • Retrospective analysis of 37 pediatric patients diagnosed with GBS between 2000 and 2016.
  • Independent reinterpretation of MRI scans by a pediatric neuroradiologist and the first author.
  • Comparison of MRI findings with clinical and laboratory data.

Main Results:

  • The study included 37 patients (59.5% boys), aged 1.5-14.8 years.
  • 73% of patients showed contrast enhancement or thickening of lumbosacral nerve roots.
  • No significant correlation was found between MRI enhancement patterns and short-term or long-term outcomes.

Conclusions:

  • Contrast-enhanced MRI is a sensitive diagnostic tool for acute inflammatory polyradiculopathy in children.
  • The predictive value of MRI enhancement patterns for clinical and therapeutic outcomes in pediatric GBS remains unproven.
Abstract